Testing and safety

SAFETATT™ • TESTING AND SAFETY

Safety supported by testing and documentation

SafeTatt™ has a professional CPSR safety assessment, has undergone dermatological and application testing, is notified in the European CPNP system, and has extensive laboratory documentation.

CPSRcosmetic product safety assessment
DERMATOLOGICALLY TESTEDfinished product testing
SENSITIVE SKINapplication study
NOT TESTED ON ANIMALSsupported by documentation

The safety of SafeTatt™ is supported by a whole set of assessments, tests and product analyses. Below we present the most important ones.

01 • SAFETY ASSESSMENT

Comprehensive CPSR safety report

The Cosmetic Product Safety Report assesses the complete product, its formulation, ingredient properties, toxicological data, instructions for use and anticipated exposure.

Final conclusion of the safety assessor:
SafeTatt™ was assessed as safe when used as intended.
✓

The assessment also covers children over 3 years old

The safety report considers use by adults and children over 3 years old.

✓

Complete formulation analysis

The safety assessor analysed the product composition and the safety of its individual components.

✓

Toxicological assessment

The documentation considers available toxicological data on ingredients and the safety of the complete formulation.

✓

No added fragrance

The product contains no fragrance or aromatic composition.

✓

Low microbiological risk

The safety documentation classifies the product as having a low microbiological risk.

✓

Positive stability assessment

The documentation includes a positive assessment of product stability and compatibility with its packaging.

✓

Not tested on animals

The safety documentation states that the finished product was not tested on animals.

✓

Professional safety assessment

The report was prepared by a qualified specialist trained in cosmetic product safety assessment.

02 • DERMATOLOGICAL TESTING

Dermatologically tested

The finished SafeTatt™ product underwent specialist dermatological testing to assess skin reaction and tolerance.

Study result:
The dermatological study found no irritating or sensitising properties in the tested product.
✓

No positive skin reactions

No positive skin reactions associated with the use of the tested product were observed.

✓

Testing of the finished product

The product was assessed in its finished form, intended for actual use by customers.

Dermatological study D/2025/11/172
03 • APPLICATION STUDY

Tested on sensitive skin

The product also underwent an application study involving actual use by people with sensitive skin.

Study result:
The product was very well tolerated during use. The study confirmed easy application, durability during everyday use and natural gradual fading.
✓

Good tolerance on sensitive skin

The application study found that the product was well tolerated on sensitive skin.

✓

Natural gradual fading

The study confirmed natural fading without leaving a permanent mark.

✓

Resistance during everyday use

The application assessment also considered resistance to contact with water and sweat.

✓

Effect lasting up to two weeks

The study also assessed the visible effect lasting up to two weeks.

Application study A/2025/12/246
04 • NO ANIMAL TESTING

The finished product was not tested on animals

The absence of animal testing on the finished product is supported by product documentation and a written statement.

SafeTatt™ was not tested on animals.
05 • PRODUCTION STANDARD

Good Manufacturing Practice documentation

The production documentation also covers Good Manufacturing Practice relating to the organisation and control of the manufacturing process.

✓

GMP standard

GMP covers requirements relating to production organisation, hygiene, process control and quality documentation.

✓

Controlled manufacturing process

Process documentation is another part of the product quality control system.

06 • EUROPEAN UNION

Notified in the European CPNP system

SafeTatt™ is notified in the European Cosmetic Products Notification Portal, the notification system for cosmetic products.

CPNP

Status: Notified

The product has been notified in the European system for cosmetic products.

07 • ADDITIONAL ANALYSIS

Independent analysis of product documentation

The dermatological and application test results have also undergone additional expert analysis.

✓

Good tolerance supported by documentation

The expert analysis considers the finished product test results and indicates good tolerance under the conditions of those studies.

08 • ADDITIONAL LABORATORY ANALYSES

Additional European and American testing

In addition to the cosmetic product documentation, the product has laboratory reports under selected European and American standards.

EN71, additional safety testing
Testing covered physical properties, flammability and migration of selected elements.
CPSIA, analysis of lead and selected phthalates
Additional laboratory analysis assessed lead and selected phthalate content.
ASTM F963
Additional testing covered physical properties, flammability and selected chemical parameters.
RoHS, analysis of selected substances
The report analyses selected substances, including lead, cadmium, mercury, hexavalent chromium and selected phthalates.
MSDS documentation
The technical documentation contains information about composition, product properties, storage and safety data.
OVERVIEW

SafeTatt™ is backed by extensive safety documentation

The product was assessed through a safety assessor, dermatological testing, an application study, expert analysis, manufacturing documentation and additional laboratory testing.

14 documents and reports relating to the product and safety
2 finished product studies involving people
4 additional laboratory testing packages
1 comprehensive CPSR safety report
✓ CPSR ✓ dermatological testing ✓ application study ✓ sensitive skin ✓ expert analysis ✓ GMP ✓ CPNP ✓ no animal testing ✓ EN71 ✓ CPSIA ✓ ASTM ✓ RoHS ✓ MSDS

All of this helps make SafeTatt™ a product that is effective and convenient to use, extensively tested and well documented.

Safety is more than one certificate

CPSR, dermatological and application studies, GMP documentation, CPNP notification, no animal testing, independent expert analysis and additional laboratory testing. This is the documentation behind SafeTatt™.